Literature DB >> 24781079

White matter hyperintensities and their penumbra lie along a continuum of injury in the aging brain.

Pauline Maillard1, Evan Fletcher1, Samuel N Lockhart1, Alexandra E Roach1, Bruce Reed1, Dan Mungas1, Charles DeCarli1, Owen T Carmichael2.   

Abstract

BACKGROUND AND
PURPOSE: Aging is accompanied by clinically silent cerebral white matter injury identified through white matter hyperintensities (WMHs) on fluid-attenuated inversion recovery (FLAIR)- and diffusion tensor imaging-based measures of white matter integrity. The temporal course of FLAIR and diffusion tensor imaging changes within WMHs and their less-injured periphery (ie, their penumbra), however, has not been fully studied. We used longitudinal diffusion tensor imaging and FLAIR to explore these changes.
METHODS: One hundred fifteen participants, aged 73.7±6.7 years, received clinical evaluations and MRIs on 2 dates. WMHs and fractional anisotropy (FA) maps were produced from FLAIR and diffusion tensor imaging and coregistered to a standardized space. Each distinct WMH was categorized as growing, stagnant, or noncontiguous incident. The penumbra of each WMH was similarly categorized as corresponding to a stagnant, growing, or noncontiguous incident WMH. Linear mixed-effect models were used to assess whether FA and FLAIR measurements changed between baseline and follow-up and differed between tissue categories.
RESULTS: Baseline FA differed significantly by tissue category, with the following ordering of categories from highest to lowest FA: penumbra of noncontiguous incident, then stagnant, then growing WMHs; noncontiguous incident, then stagnant, then growing WMHs. Despite differences in baseline values, all tissue categories experienced declines in FA over time. Only noncontiguous incident WMHs showed significant FLAIR signal increases over time, and FLAIR signal significantly decreased in stagnant WMHs.
CONCLUSIONS: WMHs and their penumbra vary in severity and together span a continuous spectrum of white matter injury that worsens with time. FLAIR fails to capture this continuous injury process fully but does identify a subclass of lesions that seem to improve over time.
© 2014 American Heart Association, Inc.

Entities:  

Keywords:  aging; diffusion tensor imaging; magnetic resonance imaging; neuroimaging

Mesh:

Year:  2014        PMID: 24781079      PMCID: PMC4102626          DOI: 10.1161/STROKEAHA.113.004084

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  27 in total

1.  Regional spatial normalization: toward an optimal target.

Authors:  P Kochunov; J L Lancaster; P Thompson; R Woods; J Mazziotta; J Hardies; P Fox
Journal:  J Comput Assist Tomogr       Date:  2001 Sep-Oct       Impact factor: 1.826

Review 2.  The declining infrastructure of the aging brain.

Authors:  David H Salat
Journal:  Brain Connect       Date:  2011

3.  Not all age-related white matter hyperintensities are the same: a magnetization transfer imaging study.

Authors:  A Spilt; R Goekoop; R G J Westendorp; G J Blauw; A J M de Craen; M A van Buchem
Journal:  AJNR Am J Neuroradiol       Date:  2006-10       Impact factor: 3.825

4.  Vascular burden and Alzheimer disease pathologic progression.

Authors:  Raymond Y Lo; William J Jagust
Journal:  Neurology       Date:  2012-09-12       Impact factor: 9.910

5.  Changes in normal-appearing white matter precede development of white matter lesions.

Authors:  Marius de Groot; Benjamin F J Verhaaren; Renske de Boer; Stefan Klein; Albert Hofman; Aad van der Lugt; M Arfan Ikram; Wiro J Niessen; Meike W Vernooij
Journal:  Stroke       Date:  2013-02-21       Impact factor: 7.914

6.  Coevolution of white matter hyperintensities and cognition in the elderly.

Authors:  Pauline Maillard; Owen Carmichael; Evan Fletcher; Bruce Reed; Dan Mungas; Charles DeCarli
Journal:  Neurology       Date:  2012-07-18       Impact factor: 9.910

7.  Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD.

Authors:  M Yoshita; E Fletcher; D Harvey; M Ortega; O Martinez; D M Mungas; B R Reed; C S DeCarli
Journal:  Neurology       Date:  2006-12-26       Impact factor: 9.910

8.  Measures of brain morphology and infarction in the framingham heart study: establishing what is normal.

Authors:  Charles DeCarli; Joseph Massaro; Danielle Harvey; John Hald; Mats Tullberg; Rhoda Au; Alexa Beiser; Ralph D'Agostino; Philip A Wolf
Journal:  Neurobiol Aging       Date:  2005-04       Impact factor: 4.673

9.  Regional pattern of white matter microstructural changes in normal aging, MCI, and AD.

Authors:  D Y Lee; E Fletcher; O Martinez; M Ortega; N Zozulya; J Kim; J Tran; M Buonocore; O Carmichael; C DeCarli
Journal:  Neurology       Date:  2009-10-21       Impact factor: 9.910

10.  Stroke risk profile predicts white matter hyperintensity volume: the Framingham Study.

Authors:  Tom Jeerakathil; Philip A Wolf; Alexa Beiser; Joseph Massaro; Sudha Seshadri; Ralph B D'Agostino; Charles DeCarli
Journal:  Stroke       Date:  2004-06-24       Impact factor: 7.914

View more
  68 in total

Review 1.  The back and forth of axonal injury and repair after stroke.

Authors:  Jason D Hinman
Journal:  Curr Opin Neurol       Date:  2014-12       Impact factor: 5.710

2.  Cooccurrence of vascular risk factors and late-life white-matter integrity changes.

Authors:  Pauline Maillard; Owen T Carmichael; Bruce Reed; Dan Mungas; Charles DeCarli
Journal:  Neurobiol Aging       Date:  2015-01-14       Impact factor: 4.673

3.  Cerebral amyloid is associated with greater white-matter hyperintensity accrual in cognitively normal older adults.

Authors:  Julia A Scott; Meredith N Braskie; Duygu Tosun; Pauline Maillard; Paul M Thompson; Michael Weiner; Charles DeCarli; Owen T Carmichael
Journal:  Neurobiol Aging       Date:  2016-08-24       Impact factor: 4.673

4.  White matter hyperintensities correlate to cognition and fiber tract integrity in older adults with HIV.

Authors:  Christa Watson; Edgar Busovaca; Jessica M Foley; I Elaine Allen; Christopher G Schwarz; Neda Jahanshad; Talia M Nir; Pardis Esmaeili-Firidouni; Benedetta Milanini; Howard Rosen; Owen T Carmichael; Paul M Thompson; Victor G Valcour
Journal:  J Neurovirol       Date:  2017-01-18       Impact factor: 2.643

5.  Aortic Stiffness, Increased White Matter Free Water, and Altered Microstructural Integrity: A Continuum of Injury.

Authors:  Pauline Maillard; Gary F Mitchell; Jayandra J Himali; Alexa Beiser; Evan Fletcher; Connie W Tsao; Matthew P Pase; Claudia L Satizabal; Ramachandran S Vasan; Sudha Seshadri; Charles DeCarli
Journal:  Stroke       Date:  2017-05-04       Impact factor: 7.914

6.  Impact of white matter hyperintensities on surrounding white matter tracts.

Authors:  William Reginold; Kevin Sam; Julien Poublanc; Joe Fisher; Adrian Crawley; David J Mikulis
Journal:  Neuroradiology       Date:  2018-07-20       Impact factor: 2.804

7.  Association of Aortic Stiffness With Cognition and Brain Aging in Young and Middle-Aged Adults: The Framingham Third Generation Cohort Study.

Authors:  Matthew P Pase; Jayandra J Himali; Gary F Mitchell; Alexa Beiser; Pauline Maillard; Connie Tsao; Martin G Larson; Charles DeCarli; Ramachandran S Vasan; Sudha Seshadri
Journal:  Hypertension       Date:  2016-01-11       Impact factor: 10.190

8.  Higher Blood Pressure Partially Links Greater Adiposity to Reduced Brain White Matter Integrity.

Authors:  Ben Allen; Matthew F Muldoon; Peter J Gianaros; J Richard Jennings
Journal:  Am J Hypertens       Date:  2016-03-12       Impact factor: 2.689

9.  Central artery stiffness, baroreflex sensitivity, and brain white matter neuronal fiber integrity in older adults.

Authors:  Takashi Tarumi; Daan L K de Jong; David C Zhu; Benjamin Y Tseng; Jie Liu; Candace Hill; Jonathan Riley; Kyle B Womack; Diana R Kerwin; Hanzhang Lu; C Munro Cullum; Rong Zhang
Journal:  Neuroimage       Date:  2015-01-24       Impact factor: 6.556

Review 10.  Binswanger's disease: biomarkers in the inflammatory form of vascular cognitive impairment and dementia.

Authors:  Gary A Rosenberg
Journal:  J Neurochem       Date:  2017-11-06       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.